ArticleOncotarget2015

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.

Marta Lionetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.